Torquetenovirus from bronchoalveolar lavage fluid as a biomarker for lung infection among immunocompromised hosts

1Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aim: Torquetenovirus (TTV) was a promising biomarker for immunity, while lung regional TTV for evaluating the opportunistic infection among immunocompromised hosts (ICH) was unclear. Materials & methods: In the ICH and non-ICH populations, we compared the susceptibility to opportunistic infections, clinical severity and the prognosis between subgroups, respectively. Results: ICH with detectable bronchoalveolar lavage fluid (BALF)-TTV were more susceptible to lung aspergillosis and Mycobacterium infections. Furthermore, our data demonstrated that the ICH cohort with detectable BALF-TTV represented a higher clinical severity and a worse prognosis, while the above findings were not found in the non-ICH population. Conclusion: Our findings demonstrated that the BALF-TTV could act as an effective predictor for opportunistic infection for ICH that complemented the CD4+ T cell counts.

References Powered by Scopus

The third international consensus definitions for sepsis and septic shock (sepsis-3)

18799Citations
N/AReaders
Get full text

Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

2050Citations
N/AReaders
Get full text

Functional effects of the microbiota in chronic respiratory disease

305Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Torquetenovirus in bronchoalveolar lavage fluid for early detection of pulmonary infections in immunocompromised hosts

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhu, Z., Wang, Y., Ning, W., Liu, C., & Chen, C. (2024). Torquetenovirus from bronchoalveolar lavage fluid as a biomarker for lung infection among immunocompromised hosts. Biomarkers in Medicine, 18(13–14), 581–591. https://doi.org/10.1080/17520363.2024.2366148

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Save time finding and organizing research with Mendeley

Sign up for free